ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

NCI-Funded Modelers Accurately Predicted Outcome Of Lung Cancer Screening Trial

November 26, 2010

Clinical Trials Approved By NCI Listed For September

September 24, 2004

What Peace Divided? Mideast Crisis Means NCI Will Be Lucky To Keep House Increase

August 31, 1990

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

Non-Caucasians At Higher Risk For Severe Breast Cancer Pain

December 28, 2007

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011